Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Boku

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagusA Ohtsu, N Boku, K Muro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2016
Identification of a FGFR3-TACC3 fusion in esophageal cancerT Mizukami, K Sakai, S Naruki, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 12, 1999
Contingent negative variation in children with anorexia nervosaK Torigoe, O Numata, T Sato, et al.
Japanese Journal of Clinical Oncology|April 1, 1997
Clinicopathological studies on coexisting gastric malignant lymphoma and gastric adenocarcinoma: report of four cases and review of the Japanese literatureT Ishihama, H Kondo, D Saito, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2010
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumorsT Doi, H Murakami, A Ohtsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2004
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LVK Shirao, P M Hoff, A Ohtsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancerK Shirao, Y Shimada, H Kondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinumN Boku, K Chin, K Hosokawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2013
Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912Y Yamada, N Boku, T Nishina, et al.
ESMO Open|December 12, 2022
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)W Okamoto, K Sakai, A Makiyama, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagusA Ohtsu, N Boku, K Muro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2016
Identification of a FGFR3-TACC3 fusion in esophageal cancerT Mizukami, K Sakai, S Naruki, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 12, 1999
Contingent negative variation in children with anorexia nervosaK Torigoe, O Numata, T Sato, et al.
Japanese Journal of Clinical Oncology|April 1, 1997
Clinicopathological studies on coexisting gastric malignant lymphoma and gastric adenocarcinoma: report of four cases and review of the Japanese literatureT Ishihama, H Kondo, D Saito, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2010
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumorsT Doi, H Murakami, A Ohtsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2004
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LVK Shirao, P M Hoff, A Ohtsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancerK Shirao, Y Shimada, H Kondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinumN Boku, K Chin, K Hosokawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2013
Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912Y Yamada, N Boku, T Nishina, et al.
ESMO Open|December 12, 2022
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)W Okamoto, K Sakai, A Makiyama, et al.
Pageof 8